Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance

Retina

Volumn 32, Issue 4, 2012, Pages 667-671

  Woo, Se Joon ^a   Han, Jeong Mo ^b   Ahn, Jeeyun ^a   Heo, Jang Won ^b   Yu, Hyeong Gon ^b   Chung, Hum ^b   Song, Junghan ^a   Park, Kyoung Un ^b   Park, Kyu Hyung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

bacterial molecular surveillance system; eubacterial polymerase chain reaction; intravitreal injection; safety profile

Indexed keywords

BEVACIZUMAB; DNA 16S; RANIBIZUMAB; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; BACTERIUM CONTAMINATION; DRUG CONTAMINATION; DRUG SAFETY; ENDOPHTHALMITIS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RETINA DETACHMENT; RETINA DISEASE; RETINA TEAR; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYRINGE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; BACTERIA; DRUG ADMINISTRATION SCHEDULE; DRUG CONTAMINATION; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETINAL DISEASES; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; TRIAMCINOLONE;

EID: 84859108320     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31822c296b     Document Type: Article

References (17)

1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358:2606-2617.
2. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:915-930.
3. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124-1133.
4. Bakri SJ, Risco M, Edwards AO, Pulido JS. Bilateral simultaneous intravitreal injections in the office setting. Am J Ophthalmol 2009;148:66-69.
5. Lima LH, Zweifel SA, Engelbert M, et al. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina 2009;29:1213-1217.
6. Lee SH, Woo SJ, Park KH, et al. Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumab. Eye (Lond) 2010;24:226-232.
7. Chiquet C, Lina G, Benito Y, et al. Polymerase chain reaction identification in aqueous humor of patients with postoperative endophthalmitis. J Cataract Refract Surg 2007;33:635-641. (Pubitemid 46505082)
8. Chiquet C, Cornut PL, Benito Y, et al. Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis. Invest Ophthalmol Vis Sci 2008;49:1971-1978.
9. Chiquet C, Maurin M, Thuret G, et al. Analysis of diluted vitreous samples from vitrectomy is useful in eyes with severe acute postoperative endophthalmitis. Ophthalmology 2009; 116:2437-2441.
10. McCabe KM, Zhang YH, Huang BL, et al. Bacterial species identification after DNA amplification with a universal primer pair. Mol Genet Metab 1999;66:205-211. (Pubitemid 29393265)
11. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002;148:257-266. (Pubitemid 34083204)
12. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol 1990;28:1942-1946. (Pubitemid 20260970)
13. Chang HE, Kim MJ, Kwon S, et al. Detection of bacterial contamination of platelets using the real-time polymerase chain reaction. Korean J Blood Transfus 2008;19:33-42.
14. Diago T, McCannel CA, Bakri SJ, et al. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 2009;29:601-605.
15. Fintak DR, Shah GK, Blinder KJ, et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008;28:1395-1399.
16. Mason JO III, White MF, Feist RM, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina 2008;28:564-567. (Pubitemid 351589565)
17. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-87. (Pubitemid 350167096)